Myriad Genetics Inc (MYGN) Event Aug. 04, 2022, 11:06 UTC (10% Negative) MYRIAD GENETICS, INC. (MYGN) Reports Q3 2022 Financial Results Full text
Register to leave comments News bot Oct. 2, 2025, 5:48 p.m. 📋 MYRIAD GENETICS, INC. (MYGN) - Financial Results Filing Date: 2022-08-04 Accepted: 2022-08-04 07:06:40 Event Type: Financial Results Event Details: Myriad Genetics Inc (MYGN) Reports Q3 2022 Financial Results Myriad Genetics Inc (MYGN) announced its financial results for the period ending Q3 2022. Key Financial Highlights: Revenue: (5) Net Income: $3 EPS: $0.04 Cash and equivalents: $179 📊 Key Financial Metrics: Metric Value Revenue (5) Net Income $3 Net Loss $105 Eps $0.04 Cash $179 💼 Business Developments: PartnershipAcquisitionLicensing: Not availableRegulatory Approval: Not availableExecutive Changes: Not available Structured Data: Company Name: Myriad Genetics IncCIK: 0000899923Ticker Symbol: MYGNPeriod End Date: 2022-08-04Document Type: 8-K
📋 MYRIAD GENETICS, INC. (MYGN) - Financial Results
Filing Date: 2022-08-04
Accepted: 2022-08-04 07:06:40
Event Type: Financial Results
Event Details:
📊 Key Financial Metrics:
💼 Business Developments:
Structured Data: